Related Topics:
Contact Us
Home | Multisystem Search | Topic Searches | System Data Searches | About the Data | Data Downloads | Widgets | Services | Mobile | Other Datasets
 
Facility ID: 45215GRNDS856RE

Facility Name and Address:
 NITTO DENKO AVECIA INC.
8560 READING RD
CINCINNATI, OH 45215

Parent Company: NITTO INC.

Industry: Pharmaceutical Preparation Manufacturing (325412)
Chemical: Toluene

Reports:
View TRI Facility profile report for this facility
View TRI Form R submissions by this facility


*You can navigate within the map with your mouse.

Production Related Waste Management for Selected Chemical


Show P2 data for other chemicals at this facility:
lchemid=0000108883
Chart Options1:



    Waste Management Comparison -



Find more P2 activities for this industry and chemical
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company


Pollution Prevention Activities for Selected Chemical

Reporting Year Section 8.10: Newly Implemented Source Reduction Activity Section 8.10: Methods to Identify Activity Section 8.11: Optional Pollution Prevention Information*
2019 Source Reduction:: W29: Other changes in inventory control
Methods to Identify SR Opportunities: T03: Materials balance audits
W29: Reduced inventory volumes for efficiency and lowering materials kept onsite.

Source Reduction - Periodic inventory assessments to assure volumes on hold are reduced to minimum needed.
2018 Source Reduction:: W29: Other changes in inventory control
Methods to Identify SR Opportunities: T03: Materials balance audits
W29: Reduced inventory volumes for efficiency and lowering materials kept onsite.

Source Reduction - Periodic inventory assessments to assure volumes on hold are reduced to minimum needed.
2017 Source Reduction:: W29: Other changes in inventory control
Methods to Identify SR Opportunities: T03: Materials balance audits
W29: Reduced inventory volumes for efficiency and lowering materials kept on-site.

Source Reduction - Periodic inventory assessments to assure volumes on hold are reduced to minimum needed.
2016 Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.

Barriers to P2: B7 - No known substitutes or alternative technologies. - Currently the oligonucleotide synthesis process and relevant R&D does not have an alternate chemical product.

Source Reduction: Source Reduction - By removing large lab suite and updating processes chemical reduction is expected.
*Classifications of Optional Pollution Prevention Information shown in brackets are provided by EPA.